These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 25658710

  • 1. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
    Flass T, Tong S, Frank DN, Wagner BD, Robertson CE, Kotter CV, Sokol RJ, Zemanick E, Accurso F, Hoffenberg EJ, Narkewicz MR.
    PLoS One; 2015; 10(2):e0116967. PubMed ID: 25658710
    [Abstract] [Full Text] [Related]

  • 2. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T, Leach ST, Katz T, Jaffe A, Day AS, Ooi CY.
    J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
    [Abstract] [Full Text] [Related]

  • 3. Probiotics in cystic fibrosis patients: A double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas/CF.
    Van Biervliet S, Hauser B, Verhulst S, Stepman H, Delanghe J, Warzee JP, Pot B, Vandewiele T, Wilschanski M.
    Clin Nutr ESPEN; 2018 Oct; 27():59-65. PubMed ID: 30144894
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children.
    Garg M, Leach ST, Coffey MJ, Katz T, Strachan R, Pang T, Needham B, Lui K, Ali F, Day AS, Appleton L, Moeeni V, Jaffe A, Ooi CY.
    J Cyst Fibros; 2017 Sep; 16(5):631-636. PubMed ID: 28416415
    [Abstract] [Full Text] [Related]

  • 5. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
    Lisowska A, Madry E, Pogorzelski A, Szydłowski J, Radzikowski A, Walkowiak J.
    Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence of intestinal inflammation in patients with cystic fibrosis.
    Werlin SL, Benuri-Silbiger I, Kerem E, Adler SN, Goldin E, Zimmerman J, Malka N, Cohen L, Armoni S, Yatzkan-Israelit Y, Bergwerk A, Aviram M, Bentur L, Mussaffi H, Bjarnasson I, Wilschanski M.
    J Pediatr Gastroenterol Nutr; 2010 Sep; 51(3):304-8. PubMed ID: 20512061
    [Abstract] [Full Text] [Related]

  • 9. Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis.
    Matamouros S, Hayden HS, Hager KR, Brittnacher MJ, Lachance K, Weiss EJ, Pope CE, Imhaus AF, McNally CP, Borenstein E, Hoffman LR, Miller SI.
    Proc Natl Acad Sci U S A; 2018 Feb 13; 115(7):1605-1610. PubMed ID: 29378945
    [Abstract] [Full Text] [Related]

  • 10. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.
    Schnapp Z, Hartman C, Livnat G, Shteinberg M, Elenberg Y.
    J Pediatr Gastroenterol Nutr; 2019 Feb 13; 68(2):282-284. PubMed ID: 30640865
    [Abstract] [Full Text] [Related]

  • 11. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O, Ohem J, Mitrova K, Durilova M, Kotalova R, Nevoral J, Kolho KL, Bronsky J.
    Clin Lab; 2014 Feb 13; 60(12):1993-2000. PubMed ID: 25651733
    [Abstract] [Full Text] [Related]

  • 12. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
    Fallahi G, Motamed F, Yousefi A, Shafieyoun A, Najafi M, Khodadad A, Farhmand F, Ahmadvand A, Rezaei N.
    Turk J Pediatr; 2013 Feb 13; 55(5):475-8. PubMed ID: 24382526
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
    Bruzzese E, Callegari ML, Raia V, Viscovo S, Scotto R, Ferrari S, Morelli L, Buccigrossi V, Lo Vecchio A, Ruberto E, Guarino A.
    PLoS One; 2014 Feb 13; 9(2):e87796. PubMed ID: 24586292
    [Abstract] [Full Text] [Related]

  • 16. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.
    Gundling F, Schmidtler F, Hapfelmeier A, Schulte B, Schmidt T, Pehl C, Schepp W, Seidl H.
    Liver Int; 2011 Oct 13; 31(9):1406-15. PubMed ID: 22093455
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A Canadian Study toward Changing Local Practice in the Diagnosis of Pediatric Celiac Disease.
    Rajani S, Huynh HQ, Shirton L, Kluthe C, Spady D, Prosser C, Meddings J, Rempel GR, Persad R, Turner JM.
    Can J Gastroenterol Hepatol; 2016 Oct 13; 2016():6234160. PubMed ID: 27446854
    [Abstract] [Full Text] [Related]

  • 19. Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.
    de Freitas MB, Moreira EAM, Tomio C, Moreno YMF, Daltoe FP, Barbosa E, Ludwig Neto N, Buccigrossi V, Guarino A.
    PLoS One; 2018 Oct 13; 13(6):e0198457. PubMed ID: 29933382
    [Abstract] [Full Text] [Related]

  • 20. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
    Egea Valenzuela J, Pereñíguez López A, Pérez Fernández V, Alberca de Las Parras F, Carballo Álvarez F.
    Rev Esp Enferm Dig; 2016 Jul 13; 108(7):394-400. PubMed ID: 27312194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.